Alkylating agent-based chemotherapy for the treatment of metastatic medullary thyroid cancer: the endocan-tuthyref experience.
Year: 2026
Type: conference-abstract
Source: Endocrine Abstracts
Authors: Noemie Simon-Tillaux, Hlne Lasolle, Yann Godbert, Cao Christine Do, Francoise Borson-Chazot, Arnaud JANNIN, Delphine DRUI, Alexandre Lugat, Stphane Bardet, Renaud Ciappuccini, Thibault Gauduchon, Romain Varnier, Camille Buffet, Johanna Wasserman, Livia Lamartina, Sophie Moog, Eric Baudin, Borget Isabelle, Sylvie Zanetta, Inna Dygai-Cochet, Cecile Chougnet, Saidi Abdellatif Nadjib, Benjamin Houot, Danielle BENISVY, Julien Hadoux
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7204759644
Cites:
Cited by:
Related to: